pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,118 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: 8k filing×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
  • phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07305779: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

    Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.. Phase: PHASE1. Conditions: Schizophrenia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07481396: Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

    Sponsor: Chungnam National University Hospital. Phase: . Conditions: Cardiac Arrest (CA), Cerebrospinal Fluid, Multiomics, Hypoxic-Ischemic Brain Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06650488: Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

    Sponsor: Todd C. Lee MD MPH FIDSA. Phase: PHASE4. Conditions: Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bloodstream Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07501988: The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients.

    Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Diabete Mellitus, İnsulin Self-management

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07487688: Five-Year CT Follow-Up of Vertebral Fracture Risk Using Opportunistic Osteoporosis Screening

    Sponsor: Technical University of Munich. Phase: . Conditions: Osteoporosis, Fracture Risk Assessment, Osteoporotic Fracture of Vertebra

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06821503: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

    Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03895203: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

    Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Psoriatic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07482527: Thoracic Mobility Versus Hip Mobility Exercises to Core Stabilization in Lumbar Spondylitis

    Sponsor: Cairo University. Phase: NA. Conditions: Individuals With Lumbar Spondylosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06561386: A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

    Sponsor: Bristol-Myers Squibb. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07174986: Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest

    Sponsor: Gabriel Riva. Phase: PHASE2. Conditions: Out of Hospital Cardiac Arrest, Ventricular Fibrillation, Defibrillation, CPR, ACLS, Sudden Death

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07500870: Comparative Evaluation of Endodontic Instrumentation Kinematics and Cryotherapy on Post-endodontic Pain and Periapical Healing

    Sponsor: All India Institute of Medical Sciences. Phase: NA. Conditions: Post Endodontic Pain, Periapical Healing

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06247670: Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype

    Sponsor: CAMP4 Therapeutics Corporation. Phase: PHASE1. Conditions: Healthy Volunteers, OTC Deficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06016842: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

    Sponsor: Ipsen. Phase: PHASE3. Conditions: Primary Biliary Cholangitis (PBC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06792786: A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

    Sponsor: The Central Hospital of Lishui City. Phase: NA. Conditions: Esophageal Cancer, ctDNA

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557186: Validity and Reliability of Kinovea Software Measurement of Lumbar Extensibility Using Modified-Modified Schober Test

    Sponsor: Cairo University. Phase: . Conditions: Lumbar Extensibility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06710769: Ovarian Tissue Cryopreservation

    Sponsor: Phoenix Children's Hospital. Phase: NA. Conditions: Infertility, Female

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07420283: A Study of Brenipatide in Participants With Opioid Use Disorder

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07576569: Nursing Intervention for Adaptation After Myocardial Revascularization

    Sponsor: Universidad de la Sabana. Phase: NA. Conditions: Coronary Artery Disease, Myocardial Revascularization, Postoperative Recovery After Cardiac Surgery, Nursing Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07347054: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)

    Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Myofascial Trigger Points, Chronic Musculoskeletal Pain, Shoulder Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06514794: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

    Sponsor: Wugen, Inc.. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05826366: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

    Sponsor: AstraZeneca. Phase: . Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03850366: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

    Sponsor: Henry Ford Health System. Phase: PHASE2. Conditions: Hematological Malignancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07516366: Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07249684: Myofascial Release And Static Stretching Along With Nighttime Bracing

    Sponsor: Riphah International University. Phase: NA. Conditions: Clubfoot Deformity

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06868784: Investigation of the Relationship Between Executive Functions and Occupational Performance of Children With Duchenne Muscular Dystrophy

    Sponsor: Lokman Hekim University. Phase: . Conditions: Executive Dysfunction, Occupational Problems, Duchenne Muscular Dystrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442084: Efficacy of Modified Si Ni San in Post-Polypectomy Management and Its Impact on Gut Microbiota in Colorectal Polyp Patients

    Sponsor: Xi'an Hospital of Traditional Chinese Medicine. Phase: NA. Conditions: Colorectal Polyps, Modified SiNiSan

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03988933: 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

    Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: PHASE2. Conditions: Latent Tuberculosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05253352: Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

    Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Lymphatic System

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07220252: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

    Sponsor: TG Therapeutics, Inc.. Phase: PHASE2. Conditions: Relapsing Multiple Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05269238: Improvement of the Performance of Lumbar Punctures After Training Students With an Augmented Reality SIMulator

    Sponsor: University Hospital, Strasbourg, France. Phase: NA. Conditions: Lumbar Puncture

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07440238: Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Septic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07171138: This Study Will Use Real-time Pressure Mapping Technology to Determine Which Positioning Strategies and Devices Exert the Least Amount of Pressure on Peri-operative Burn Patients

    Sponsor: Sunnybrook Health Sciences Centre. Phase: NA. Conditions: Hospital Acquired Pressure Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06870058: A Study of NH280105 in Healthy Adult Participants

    Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Alzheimer Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01212055: Apheresis of Patients With Immunodeficiency

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: LAD-1, DOCK8, GATA2 Deficancy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06751355: Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

    Sponsor: Washington University School of Medicine. Phase: . Conditions: Kaposi Sarcoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07359352: Surgical Care And Recovery With Laser Evaluation Trial (SCARLET)

    Sponsor: AdventHealth. Phase: NA. Conditions: Post-surgical Scars, Hypertrophic Scars, Scar Appearance Dissatisfaction, Aesthetic Surgical Outcomes, Wound Healing After Body-contouring Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04859543: Pediatric Prospective Personalized Immune and Target Identification Trial

    Sponsor: Masaryk University. Phase: NA. Conditions: Central Nervous System Neoplasms, Pediatric Cancer, GEN1 Gene Mutation, Tumor, Brain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06970743: A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

    Sponsor: BeOne Medicines. Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05661643: The Efficacy and Safety of Temozolomide in SDH-deficient GIST

    Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Gastrointestinal Stromal Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06855043: Little Lungs Study

    Sponsor: University of Wisconsin, Madison. Phase: PHASE1. Conditions: Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05274243: 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00200343: Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Hepatitis C

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06722508: Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

    Sponsor: University of California, Davis. Phase: NA. Conditions: Head Cancer, Neck Cancer, Sarcopenia, Head and Neck Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07484308: Application and Impact Assessment of Ultrasound Super-Resolution Blood Flow Imaging (URM) in Patients With Renal Failure

    Sponsor: Ma Zhe. Phase: NA. Conditions: Kidney Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06331325: Comparison of Frenotomy and Frenectomy Techniques for Management of High Frenum Attachment in Adults

    Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: High Frenum Attachment

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06649825: Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.

    Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Familial Adenomatous Polyposis (FAP)

    full page →ctgov ↗
    ›TEMPORARILY_NOT_AVAILABLEphase readoutNCT06169176: RAPA-501 Therapy of ALS Expanded Access Protocol

    Sponsor: Rapa Therapeutics LLC. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07122089: Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

    Sponsor: Center Eugene Marquis. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05024968: Sintilimab in Cancer of Unknown Primary

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cancer of Unknown Primary Site

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04841668: Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly

    Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta. Phase: . Conditions: Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ← prev
    page 75 of 143
    next →